ESTOOLS - Advances with human embryonic stem cells -

estools logo

3rd ETHICS WORKSHOP

"do we still need human embryonic stem cells?"

Friday 28 May
Gulbenkian Foundation, Lisbon, Portugal

Organiser: Göran Hermerén - ESTOOLS / Lund University / European Group on Ethics in Science & New Technologies


Registration: Registration to worshop is free.

Symposium participants: tick the relevant box to register on the symposium online registration.

Non-symposium participants: Workshop only registration (no access to the symposium sessions)


Programme:

14:00  Welcome from the organiser

SESSION A: Scientific aspects: comparison of ES to iPS cells.

CHAIR: Göran Hermerén

14:10 Nissim Benvenisty Hebrew University of Jerusalem: "Differential modelling of Fragile X Syndrome by human ES and iPS cells"

SESSION B: Ethical, societal and regulatory aspects, including public perception.

CHAIR: Demetrio Neri - ESTOOLS Ethics Advisory panel / University of Messina

14:35 Margarida Menezes-Ferreira - INFARMED National Authority of Medicines & Health Products, Portugal / European Committee for Advanced Therapy Medicinal Products: "Regulating stem cells"

15:00 Giuseppe Testa - European Institute of Oncology  "Why society still needs hESCs"

15:25 Christian Desaintes - European Commission - DG Research, Health Infectious diseases (to be confirmed)

15:45  COFFEE BREAK

SESSION C: IPR, patentability, commercialisation.

CHAIR: Kate Millar - ESTOOLS Ethics Advisory panel / University of Nottingham, Centre for Applied Bioethics

16:10 Clara Sattler de Sousa e Brito Yale Law School "The ECJ-case and strategies for stem cell patenting"

16:35 Aliki Nichogiannopoulou and Christof Friedrich EPO Munich "Patentability of embryo-derived versus induced pluripotent stem cells"

17:00  ROUND TABLE

CHAIR: Göran Hermerén

Participants: Eurico Reis (Conselho Nacional de Procriação Medicamente Assistida) and speakers, policymakers, regulators and others

18:00  Workshop closing words

 

 

Advertisement on page 15 of May 2010 Newsletter of Calouste Gulbenkian Foundation 

 

Click to open the news item in larger size